Diagnosis, Differential Diagnosis, Staging and Time Course of Dementia

来源 :2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大 | 被引量 : 0次 | 上传用户：liongliong546

【摘要】

：

　　The definition of normal aging and overview of Alzheimers disease will be presented including the diagnosis and differential diagnosis of dementia.Risk fact

【作者】

：

Istvan J.E.Boksay

【机构】

：

NewYorkUniversityUSA

【出处】

：

2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大

【发表日期】

：

2015年11期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　The definition of normal aging and overview of Alzheimers disease will be presented including the diagnosis and differential diagnosis of dementia.Risk factors to develop Alzbeimers disease will be presented.The clinical features,stages and time course of Alzheimers disease will be discussed.The global deterioration scale IGDS) will be presented.

其他文献

PKPD modeling and simulation and its application in the optimization of therapeutic regimens of anti

Cancer therapy PD of Irreversible Effects: Phase-nonspecific PD of Irreversible Effects: Phase-nonspecific PD of Irreversible Effects: Cell-cycle Specific

会议

Innovation in China Through Collaborative Research Organization(CRO)

BIODURO The Spring is here! The Spring of Drug Discovery in China is here Talents Policy Money Entrepreneurship Basic research

会议

良好药典规范(Gphp)全球协调性之业界视角

致谢中国外商投资企业协会药品研制和开发行业委员会(RDPAC)的成员-默沙东中国有限公司,Wendy Yu-罗氏(中国)控股有限公司,Melly Lin

会议

Cardiovascular Safety During Oncology Drug Development

Were developing treatments for cancer Why worry about rare cardiac side effects?

会议

乌克兰国家药典现状与未来

乌克兰国家药典的地位:根据药品法乌克兰国家药典是一部法案.药典的要求对生产,贮藏,分发和使用药品的所有乌克兰企业和院校具有强制性,不管他们的所有权如何.

会议

Regenerated Human Myocardium-developing Novel Cellular Therapy for Anti-Heart Failure

Background Stem Cell Based Technologies have become a Therapeutic Strategy Cellular Replacement & Repair Biomaterials & Organ Regeneration Immunology and Micro-

会议

FIRST-IN-HUMAN PHASE 1 STUDY OF ETC-159 AN ORAL PORCN INHIBITOR IN PATIENTS WITH ADVANCED SOLID TUMO

OBJECTIVES Primary: Maximum Tolerated Dose (MTD) and Recommended Dose (RD).Secondary: Safety, Tolerability and Pharmacokinetics (PK).Exploratory: Pharmacodynami

会议

Building Blocks Enabled Drug Discovery (Selected Slides)

　　--An introduction to a catalog of 30,000 plus novel building blocks, which are designed by analysis of the structures of a large number of real marketed and

会议

A New Paradigm of Drug Safety Evaluation for Emerging Therapies

Introduction It has been more than 50 years that preclinical drug safety evaluation is conducted to support clinical studies and marketing approval of a new dru

会议

Ion Channels Their Discovery, Their Function, and Their Role in Pharmacology and Pathophysiology, In

　　The discovery of ion channels and the development of highly sensitive methods to explore their function has opened multiple new paths for the study of human

会议

Diagnosis, Differential Diagnosis, Staging and Time Course of Dementia

与本文相关的学术论文